Market Indices
Sector Heatmap
COAG — Hemab Therapeutics Holdings, Inc. Common Stock
NasdaqHemab Therapeutics Holdings, Inc. Common Stock
- O
- 31.49
- H
- 31.49
- L
- 30.06
- V
- 354.14K
COAG — Latest News & Headlines
14 StoriesHemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? - Yahoo Finance
Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? Yahoo Finance
Hemab Therapeutics Holdings (Nasdaq:COAG) - Stock Analysis - Simply Wall Street
Hemab Therapeutics Holdings (Nasdaq:COAG) - Stock Analysis Simply Wall Street
$COAG stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
$COAG stock is down 8% today. Here's what we see in our data. Quiver Quantitative
Director Walbert Keli's option carries a $35.72 exercise price at Hemab Therapeutics (COAG). - Stock Titan
Director Walbert Keli's option carries a $35.72 exercise price at Hemab Therapeutics (COAG). Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Shares Gap Down - Here's What Happened - MarketBeat
Hemab Therapeutics (NASDAQ:COAG) Shares Gap Down - Here's What Happened MarketBeat
Hemab Therapeutics: The Market Is Pricing One Rung Of A Four-Rung Ladder (NASDAQ:COAG) - Seeking Alpha
Hemab Therapeutics: The Market Is Pricing One Rung Of A Four-Rung Ladder (NASDAQ:COAG) Seeking Alpha
Walbert Keli is listed as a director of Hemab Therapeutics (COAG) in an initial ownership statement. - Stock Titan
Walbert Keli is listed as a director of Hemab Therapeutics (COAG) in an initial ownership statement. Stock Titan
Can Hemab Therapeutics Holdings (COAG) Justify Its Valuation After Russell Index Inclusion? - Simply Wall Street
Can Hemab Therapeutics Holdings (COAG) Justify Its Valuation After Russell Index Inclusion? Simply Wall Street
Hemab Therapeutics Holdings, Inc.(NasdaqGS: COAG) added to S&P Global BMI Index - marketscreener.com
Hemab Therapeutics Holdings, Inc.(NasdaqGS: COAG) added to S&P Global BMI Index marketscreener.com
Hemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat
Hemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading Volume - Still a Buy? MarketBeat
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of "Moderate Buy" from Analysts MarketBeat
Hemab Therapeutics Holdings (COAG) Begins Phase 1 Dosing For HMB 003 - Simply Wall Street
Hemab Therapeutics Holdings (COAG) Begins Phase 1 Dosing For HMB 003 Simply Wall Street
76,900 Shares in Hemab Therapeutics Holdings, Inc. $COAG Bought by State Street Corp - MarketBeat
76,900 Shares in Hemab Therapeutics Holdings, Inc. $COAG Bought by State Street Corp MarketBeat
Hemab Therapeutics (NASDAQ:COAG) Shares Down 5.7% - What's Next? - MarketBeat
Hemab Therapeutics (NASDAQ:COAG) Shares Down 5.7% - What's Next? MarketBeat